sellModerate cluster of 310b5-1 plan
Anirvan Ghosh sold $100k of UBX
Chief Executive Officer at Unity Biotechnology, Inc.. 96,797 shares at an average of $1.03, traded Apr 2, 2025, filed Apr 3, 2025.
Warning score
40Value
$100k
96,797 shares
Holdings after
153,454
-39% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +10Trade size$100k at market
- +10Share of holdings soldSold 39% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-25-050397, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 2, 2025 | SOpen-market sale Common Stock, $0.0001 par value10b5-1 | -96,797 | $1.03 | $100k | 153,454 | Apr 3, 2025 |
Related signals
Other insiders at Unity Biotechnology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | Unity Biotechnology, Inc. | Alexander Hieu Nguyen CLO and Head of Ops | $18k 17,852 shares | -27% | |
| 22Weak | Unity Biotechnology, Inc. | Lynne Marie Sullivan CFO & Head of Corp. Dev. | $23k 21,867 shares | -18% | |
| 5Weak | Unity Biotechnology, Inc. | Anirvan Ghosh Chief Executive Officer | $1,432 642 shares | -1% | |
| 20Weak | Unity Biotechnology, Inc. | Anirvan Ghosh Chief Executive Officer | $557 432 shares | -1% | |
| 10Weak | Unity Biotechnology, Inc. | Alexander Hieu Nguyen Chief Legal Officer | $192 149 shares | -1% | |
| 17Weak | Unity Biotechnology, Inc. | Lynne Marie Sullivan CFO & Head of Corp. Dev. | $175 136 shares | -0% | |
| 5Weak | Unity Biotechnology, Inc. | Anirvan Ghosh Chief Executive Officer | $1,078 589 shares | -1% | |
| 5Weak | Unity Biotechnology, Inc. | Anirvan Ghosh Chief Executive Officer | $1,946 1,024 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.